🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine safety and preliminary efficacy o...
Status
Recruiting
Location
University of California at San Diego Moores Cancer Center
Start Date
2024-04-22
Trial ID
NCT06385080
Treatments Being Tested
To learn if the combination of amivantamab and tepotinib can help to contro...
Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-06-18
Trial ID
NCT06083857
Treatments Being Tested
The purpose of this expanded access program (EAP) is to provide amivantamab...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04599712
Treatments Being Tested
The purpose of this study is to see whether the study drug, amivantamab, is...
Status
Active Not Recruiting
Location
University of California, Irvine
Start Date
2021-12-02
Trial ID
NCT05117931
Treatments Being Tested
This study will assess the safety and efficacy of Osimertinib with Amivanta...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-07-18
Trial ID
NCT05801029
Treatments Being Tested
AMAZE-lung is a multicenter single-arm phase II trial. The protocol treatme...
Status
Active Not Recruiting
Location
Chu Angers
Start Date
2023-03-27
Trial ID
NCT05601973
Treatments Being Tested
The primary objective of this study is to determine the feasibility of four...
Status
Recruiting
Location
Jessa Ziekenhuis, Department of Pneumology
Start Date
2024-11-06
Trial ID
NCT06784791
Treatments Being Tested
The purpose of this study is to compare the efficacy, as demonstrated by pr...
Status
Active Not Recruiting
Location
City of Hope 2
Start Date
2020-10-13
Trial ID
NCT04538664
Treatments Being Tested
This is a Phase 1 dose-finding study of FT536 given in combination with a m...
Status
Terminated
Location
Honor Health Research Institute
Start Date
2022-05-31
Trial ID
NCT05395052
The purpose of this clinical trial is to evaluate the safety and tolerabili...
Status
Active Not Recruiting
Location
Cambridge University Hospitals
Start Date
2024-10-09
Trial ID
NCT06632236
Treatments Being Tested